Just when you think a politician couldn’t embarrass themselves any more than Chris Bowen with his painful petrol press ...

On an unseasonably warm day in Chicago, Blake Mohseni stepped out for a walk and fielded a call about a school his 3-year-old daughter is still too young to attend. Mohseni — who works in finance and ...

A reckless incident at a party throws a young girl’s life into turmoil in this extraordinary third feature from Julia Ducournau. By Jeannette Catsoulis When you purchase a ticket for an independently ...

For decades, investors and academics have been locked in a hunt for alpha—the holy grail of risk-adjusted returns that can’t be explained by known market factors. The quest has grown so frenzied it ...

CAMBRIDGE, Mass. and NEW ORLEANS – March 25, 2026 - Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, ...

New findings highlight correlations between EEG and clinical outcome measures in Alzheimer’s disease Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive ...

"Mission success! Alpha Flight 7 achieved nominal performance and validated key systems ahead of our Block II configuration upgrade." When you purchase through links on our site, we may earn an ...

Firefly Aerospace’s Alpha rocket lifts off March 11 from Vandenberg Space Force Base. Credit: Firefly Aerospace WASHINGTON — Firefly Aerospace’s Alpha rocket successfully returned to flight March 11, ...

Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. Cognito Therapeutics announced a $105 million Series C round ...

Cognito Therapeutics, which is in late-stage development of its device to treat neurodegenerative diseases like Alzheimer’s, hauled in $105 million in an oversubscribed series C funding round. The ...

Cognito Therapeutics, a company using visual and auditory stimulation to treat neurodegenerative disorders, announced it closed an oversubscribed $105 million Series C funding round. Morningside ...